The trademark application was filed by PFIZER INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 3, 2023, and it was registered by office on January 10, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with pharmaceutical preparations for the treatment of hemophilia, genetic disorders, and blood disorders.
The mark was filed in class 44 with Providing medical information in the field of hemophilia, genetic disorders, blood disorders, and the treatment thereof.